Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Mov Disord ; 35(4): 698-703, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-31872915

RESUMEN

BACKGROUND: Autonomic dysfunction is a well-known dominant symptom in the advanced stages of Parkinson's disease. However, the role of cardiac sympathetic nerves still needs to be elucidated. OBJECTIVES: To evaluate cardiac sympathetic response in Parkinsonian and dyskinetic monkeys. METHODS: Adult male monkeys were divided into 1 of the following 3 groups: controls, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine+levodopa-treated animals. Noradrenaline, its metabolite normetanephrine, and phospho-Heat shock proten 27 (p-Hsp27) at serine 82 levels were analyzed in the left and right ventricles of the heart. Tyrosine hydroxylase immunohistochemistry was performed in the ventral mesencephalon. RESULTS: The results were the following: (1) 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication significantly increased normetanephrine levels and decreased noradrenaline turnover in the right ventricle without changes in the left ventricle; however, (2) levodopa treatment decreased noradrenaline levels and enhanced the normetanephrine/noradrenaline ratio in parallel with a very significant increase of Hsp27 activity in both ventricles. CONCLUSIONS: Levodopa treatment could induce protective cardiac effects through the increased Hsp27 activity. © 2019 International Parkinson and Movement Disorder Society.


Asunto(s)
Discinesias/metabolismo , Proteínas de Choque Térmico HSP27 , Norepinefrina , 1-Metil-4-fenil-1,2,3,6-Tetrahidropiridina , Animales , Levodopa , Macaca fascicularis , Masculino , Fosforilación , Tirosina 3-Monooxigenasa/metabolismo
2.
J Agric Food Chem ; 71(31): 11921-11928, 2023 Aug 09.
Artículo en Inglés | MEDLINE | ID: mdl-37494568

RESUMEN

Urolithins are gut microbiota metabolites of ellagic acid. Here, we have identified and chemically characterized a novel urolithin produced from urolithin D (3,4,8,9-tetrahydroxy urolithin) by in vitro incubation with different human gut Enterocloster species under anaerobic conditions. Urolithin G (3,4,8-trihydroxy urolithin) was identified by 1H NMR, 13C NMR, UV, HRMS, and 2D NMR. For the identification, NMR spectra of other known urolithins were also recorded and compared. Urolithin G was present in the feces of 12% of volunteers in an overweight-obese group after consuming an ellagitannin-rich pomegranate extract. The production of urolithin G required a bacterial 9-dehydroxylase activity and was not specific to the known human urolithin metabotypes A and B. The ability to produce urolithin G could be considered an additional metabolic feature for volunteer stratification and bioactivity studies. This is the first urolithin with a catechol group in ring A while having only one hydroxyl in ring B, a unique feature not found in human and animal samples so far.


Asunto(s)
Microbioma Gastrointestinal , Obesidad , Animales , Humanos , Heces/microbiología , Obesidad/metabolismo , Sobrepeso , Cumarinas/química , Taninos Hidrolizables/metabolismo
3.
Sci Rep ; 11(1): 19871, 2021 10 06.
Artículo en Inglés | MEDLINE | ID: mdl-34615910

RESUMEN

The impact of age-associated disorders is increasing as the life expectancy of the population increments. Cardiovascular diseases and neurodegenerative disorders, such as Parkinson's disease, have the highest social and economic burden and increasing evidence show interrelations between them. Particularly, dysfunction of the cardiovascular nervous system is part of the dysautonomic symptoms of Parkinson's disease, although more studies are needed to elucidate the role of cardiac function on it. We analyzed the dopaminergic system in the nigrostriatal pathway of Parkinsonian and dyskinetic monkeys and the expression of some key proteins in the metabolism and synthesis of catecholamines in the heart: total and phosphorylated (phospho) tyrosine hydroxylase (TH), and membrane (MB) and soluble (S) isoforms of catechol-O-methyl transferase (COMT). The dopaminergic system was significantly depleted in all MPTP-intoxicated monkeys. MPTP- and MPTP + L-DOPA-treated animals also showed a decrease in total TH expression in both right (RV) and left ventricle (LV). We found a significant increase of phospho-TH in both groups (MPTP and MPTP + L-DOPA) in the LV, while this increase was only observed in MPTP-treated monkeys in the RV. MB-COMT analysis showed a very significant increase of this isoform in the LV of MPTP- and MPTP + L-DOPA-treated animals, with no significant differences in S-COMT levels. These data suggest that MB-COMT is the main isoform implicated in the cardiac noradrenergic changes observed after MPTP treatment, suggesting an increase in noradrenaline (NA) metabolism. Moreover, the increase of TH activity indicates that cardiac noradrenergic neurons still respond despite MPTP treatment.


Asunto(s)
Catecol O-Metiltransferasa/metabolismo , Proteínas de la Membrana/metabolismo , Tirosina 3-Monooxigenasa/metabolismo , Animales , Biomarcadores , Catecol O-Metiltransferasa/genética , Cuerpo Estriado/metabolismo , Dopamina/metabolismo , Neuronas Dopaminérgicas/metabolismo , Activación Enzimática , Inmunohistoquímica , Macaca fascicularis , Masculino , Enfermedad de Parkinson/etiología , Enfermedad de Parkinson/metabolismo , Enfermedad de Parkinson/patología , Fosforilación , Tirosina 3-Monooxigenasa/genética
4.
Future Microbiol ; 13: 1215-1223, 2018 09.
Artículo en Inglés | MEDLINE | ID: mdl-30238774

RESUMEN

AIM: To test the synergistic effect of Cpl-711 endolysin and antibiotics for antipneumococcal activity. MATERIALS & METHODS: A combination of Cpl-711 and different antibiotics (amoxicillin, cefotaxime, levofloxacin and vancomycin) was tested in a checkerboard assay against several multidrug-resistant Streptococcus pneumoniae strains. Mouse and zebrafish models of pneumococcal sepsis were used to confirm the in vitro data. RESULTS: The activity of Cpl-711 combined with amoxicillin or cefotaxime was synergistic in the bactericidal effect against a serotype 23F multiresistant clinical isolate of S. pneumoniae. Synergy between Cpl-711 and cefotaxime was validated using both mouse and zebrafish models. CONCLUSION: Combination of Cpl-711 and cefotaxime may help in the treatment of diseases caused by multiresistant pneumococcal strains.


Asunto(s)
Antibacterianos/farmacología , Farmacorresistencia Bacteriana Múltiple , Muramidasa/farmacología , Infecciones Neumocócicas/microbiología , Proteínas Recombinantes de Fusión/farmacología , Sepsis/microbiología , Streptococcus pneumoniae/efectos de los fármacos , Animales , Antibacterianos/uso terapéutico , Cefotaxima/farmacología , Cefotaxima/uso terapéutico , Modelos Animales de Enfermedad , Sinergismo Farmacológico , Femenino , Ratones , Ratones Endogámicos BALB C , Muramidasa/uso terapéutico , Infecciones Neumocócicas/tratamiento farmacológico , Proteínas Recombinantes de Fusión/uso terapéutico , Sepsis/tratamiento farmacológico , Fagos de Streptococcus/enzimología , Pez Cebra
5.
Sci Rep ; 8(1): 6965, 2018 05 03.
Artículo en Inglés | MEDLINE | ID: mdl-29725038

RESUMEN

Parkinson's disease (PD) is an age-related neurodegenerative disease associated with the misfolding and aggregation of alpha-synuclein (aSyn). The molecular underpinnings of PD are still obscure, but nutrition may play an important role in the prevention, onset, and disease progression. Dietary (poly)phenols revert and prevent age-related cognitive decline and neurodegeneration in model systems. However, only limited attempts were made to evaluate the impact of digestion on the bioactivities of (poly)phenols and determine their mechanisms of action. This constitutes a challenge for the development of (poly)phenol-based nutritional therapies. Here, we subjected (poly)phenols from Arbutus unedo to in vitro digestion and tested the products in cell models of PD based on the cytotoxicity of aSyn. The (poly)phenol-digested metabolites from A. unedo leaves (LPDMs) effectively counteracted aSyn and H2O2 toxicity in yeast and human cells, improving viability by reducing aSyn aggregation and inducing its clearance. In addition, LPDMs modulated pathways associated with aSyn toxicity, such as oxidative stress, endoplasmic reticulum (ER) stress, mitochondrial impairment, and SIR2 expression. Overall, LPDMs reduced aSyn toxicity, enhanced the efficiency of ER-associated protein degradation by the proteasome and autophagy, and reduced oxidative stress. In total, our study opens novel avenues for the exploitation of (poly)phenols in nutrition and health.


Asunto(s)
Polifenoles/farmacología , Agregado de Proteínas/efectos de los fármacos , Proteostasis/efectos de los fármacos , alfa-Sinucleína/metabolismo , Autofagia/efectos de los fármacos , Línea Celular , Ericaceae/química , Humanos , Peróxido de Hidrógeno/metabolismo , Estrés Oxidativo/efectos de los fármacos , Enfermedad de Parkinson/metabolismo , Enfermedad de Parkinson/terapia , Polifenoles/química
6.
Artículo en Inglés | MEDLINE | ID: mdl-28676846

RESUMEN

Antibacterial treatment with cotrimoxazol (TxS), a combination of trimethoprim and sulfamethoxazole, generates resistance by, among others, acquisition of thymidine auxotrophy associated with mutations in the thymidylate synthase gene thyA, which can modify the biology of infection. The opportunistic pathogen non-typeable Haemophilus influenzae (NTHi) is frequently encountered in the lower airways of chronic obstructive pulmonary disease (COPD) patients, and associated with acute exacerbation of COPD symptoms. Increasing resistance of NTHi to TxS limits its suitability as initial antibacterial against COPD exacerbation, although its relationship with thymidine auxotrophy is unknown. In this study, the analysis of 2,542 NTHi isolates recovered at Bellvitge University Hospital (Spain) in the period 2010-2014 revealed 119 strains forming slow-growing colonies on the thymidine low concentration medium Mueller Hinton Fastidious, including one strain isolated from a COPD patient undergoing TxS therapy that was a reversible thymidine auxotroph. To assess the impact of thymidine auxotrophy in the NTHi-host interplay during respiratory infection, thyA mutants were generated in both the clinical isolate NTHi375 and the reference strain RdKW20. Inactivation of the thyA gene increased TxS resistance, but also promoted morphological changes consistent with elongation and impaired bacterial division, which altered H. influenzae self-aggregation, phosphorylcholine level, C3b deposition, and airway epithelial infection patterns. Availability of external thymidine contributed to overcome such auxotrophy and TxS effect, potentially facilitated by the nucleoside transporter nupC. Although, thyA inactivation resulted in bacterial attenuation in a lung infection mouse model, it also rendered a lower clearance upon a TxS challenge in vivo. Thus, our results show that thymidine auxotrophy modulates both the NTHi host airway interplay and antibiotic resistance, which should be considered at the clinical setting for the consequences of TxS administration.


Asunto(s)
Farmacorresistencia Microbiana/efectos de los fármacos , Infecciones por Haemophilus/tratamiento farmacológico , Haemophilus influenzae/crecimiento & desarrollo , Haemophilus influenzae/metabolismo , Timidilato Sintasa/genética , Células A549 , Animales , Antibacterianos/farmacología , Proteínas Bacterianas/genética , Línea Celular Tumoral , ADN Bacteriano , Femenino , Genes Bacterianos/genética , Infecciones por Haemophilus/microbiología , Infecciones por Haemophilus/patología , Haemophilus influenzae/citología , Haemophilus influenzae/genética , Interacciones Huésped-Patógeno , Humanos , Interleucina-8/metabolismo , Pulmón/microbiología , Pulmón/patología , Ratones , Microscopía Electrónica de Transmisión , Mutación , Infecciones del Sistema Respiratorio/microbiología , Infecciones del Sistema Respiratorio/patología , España , Sulfametoxazol/farmacología , Timidina/metabolismo , Trimetoprim/farmacología , Combinación Trimetoprim y Sulfametoxazol/farmacología , Virulencia/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA